Cross Reach Inc. – Trademark Portfolio
Entity Type: 03
Cross Reach Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered and 3 are pending. Notable registered marks include KAGURA.
Office No. 403 PILEKUDAN,
1-14-16, Kudan-kita, Chiyoda-ku Tokyo 102-0073
Showing of trademarks Trademarks
Trademark Classifications
Cross Reach Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Cross Reach Inc. have?
Cross Reach Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 pending.
What trademark classes does Cross Reach Inc. file in?
Cross Reach Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 30 (Staple Foods). Class 35 covers advertising; business management; business administration; office functions.
What are Cross Reach Inc.'s most well-known trademarks?
Cross Reach Inc.'s registered trademark portfolio includes well-known marks such as KAGURA. These are among 1 currently registered trademark in the portfolio.
What is Cross Reach Inc.'s trademark registration success rate?
Cross Reach Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 3 applications are pending review.